Koligo Therapeutics to Participate in Maxim Group and M-Vest COVID-19 Virtual Conference Series on May 27, 2020
NEW ALBANY, INDIANA, UNITED STATES, May 22, 2020 /EINPresswire.com/ -- Koligo Therapeutics, Inc. (Koligo), a privately-held regenerative medicine company, today announced that Matthew Lehman, Chief Executive Officer, will be participating in the Maxim …